Skip to main content
. 2013 May 13;48(5):1669–1683. doi: 10.1111/1475-6773.12063

Table 1.

Patient Characteristics for Treatment Cohort [n = 54,592] (n, %)*

Characteristic White (n = 48,626) Black (n = 3,623) Hispanic (n = 2,343) p-Value
Age
 66–70 14,027 (29) 1,253 (35) 848 (36) <.0001
 71–75 14,145 (29) 1,096 (30) 735 (31)
 76–80 11,747 (24) 751 (21) 464 (20)
 81–85 6,404 (13) 375 (10) 222 (9)
 >85 2,303 (5) 148 (4) 74 (3)
Socioeconomic status
Median income
 Quartile 1 (lowest) 8,646 (18) 2,142 (59) 931 (40) <.0001
 Quartile 2 11,573 (24) 806 (22) 618 (26)
 Quartile 3 12,948 (27) 409 (11) 467 (20)
 Quartile 4 (highest) 15,089 (31) 246 (7) 314 (13)
High school (HS) diploma rates
 Quartile 1 (areas w/lowest HS graduation rates) 8,219 (17) 2,018 (56) 1,225 (52) <.0001
 Quartile 2 11,705 (24) 887 (24) 515 (22)
 Quartile 3 13,231 (27) 471 (13) 350 (15)
 Quartile 4 (highest HS graduation rates) 15,101 (31) 227 (6) 240 (10)
 Unknown socioeconomic status (zip code) 370 (0.8) 20 (0.6) 13 (0.6)
Marital status
 Married 23,342 (48) 999 (28) 964 (41) <.0001
 Single 23,772 (49) 2,484 (69) 1,322 (56)
 Unknown 1,512 (3) 140 (4) 57 (2)
Charlson comorbidity
 0 43,213 (89) 2,807 (77) 1,979 (84) <.0001
 1 3,652 (8) 486 (13) 236 (10)
 ≥2 1,761 (4) 330 (9) 128 (5)
Year of diagnosis
 1992 1,623 (3) 137 (4) 80 (3) <.0001
 1993 1,618 (3) 129 (4) 46 (2)
 1994 1,665 (3) 121 (3) 73 (3)
 1995 1,746 (4) 147 (4) 69 (3)
 1996 1,758 (4) 122 (3) 85 (4)
 1997 1,878 (4) 139 (4) 82 (4)
 1998 1,887 (4) 141 (4) 79 (3)
 1999 2,001 (4) 146 (4) 93 (4)
 2000 4,257 (9) 313 (9) 199 (8)
 2001 4,439 (9) 290 (8) 182 (8)
 2002 4,519 (9) 304 (8) 179 (8)
 2003 4,358 (9) 343 (9) 223 (10)
 2004 4,418 (9) 347 (10) 212 (9)
 2005 4,139 (9) 324 (9) 269 (11)
 2006 4,183 (9) 303 (8) 241 (10)
 2007 4,137 (9) 317 (9) 231 (10)
Tumor size
 ≤2 cm 22,455 (46) 1,323 (37) 857 (37) <.0001
 2.1–3.0 cm 5,013 (10) 447 (12) 273 (12)
 >3 cm 3,934 (8) 518 (14) 245 (10)
 Unknown 17,224 (35) 1,335 (37) 968 (41)
Number of nodes positive
 0 29,037 (60) 1,857 (51) 1,288 (55) <.0001
 1–3 8,255 (17) 764 (21) 474 (20)
 4–9 2,972 (6) 362 (10) 209 (9)
 ≥ 10 1,578 (3) 157 (4) 95 (4)
 Unknown 6,784 (14) 483 (13) 277 (12)
Stage at diagnosis
 I 28,382 (58) 1,598 (44) 1,130 (48) <.0001
 II 16,491 (34) 1,549 (43) 963 (41)
 III 3,753 (8) 476 (13) 250 (11)
Tumor grade
 Well differentiated 10,931 (22) 499 (14) 462 (20) <.0001
 Moderately differentiated 19,899 (41) 1,201 (33) 893 (38)
 Poorly differentiated/undifferentiated 13,146 (27) 1,466 (40) 756 (33)
 Unknown 4,650 (10) 457 (13) 232 (10)
Hormone receptor status
 Hormone receptor-positive 23,004 (47) 1,369 (38) 899 (38) <.0001
 Hormone receptor-negative 3,864 (8) 494 (14) 208 (9)
 Unknown receptor status 21,758 (45) 1,760 (49) 1,236 (53)
Surgery received
 Mastectomy 13,036 (27) 1,426 (39) 818 (35) <.0001
 Breast conserving surgery 35,590 (73) 2,197 (61) 1,525 (65)
SEER registry
 Connecticut 6,392 (13) 200 (6) 131 (6) <.0001
 Detroit 5,348 (11) 1,028 (28) 57 (2)
 New Mexico 1,154 (2) 264 (11)
 Seattle 4,728 (10) 58 (2) 24 (1)
 Atlanta and rural Georgia 1,966 (4) 430 (12) 28 (1)
 Kentucky 2,835 (6)
 Louisiana 2,227 (5) 461 (13) 20 (9)
 New Jersey 6,401 (13) 515 (14) 211 (9)
 California 17,575 (36) 796 (22) 1,599 (68)
County
 Major metropolitan 32,499 (67) 2,887 (80) 1,560 (67) <.0001
 Metropolitan 11,747 (24) 570 (16) 618 (26)
 Urban 2,474 (5) 81 (2) 60 (3)
 Less urban 1,623 (3)
 Rural 283 (0.6)
*

Differences examined using chi-square testing. Percentages within categories may not sum to 100% due to rounding.

Cell sizes suppressed for reasons of confidentiality if at least one column and/or row had sample sizes <11.